Mint Tower Capital Management B.V. »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 11M 1.12

More positions owned by Mint Tower Capital Management B.V.

On Semiconductor Corp Note 1.625%10/1 (Principal)
Carnival Corp Note 5.750%10/0 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Palo Alto Networks Note 0.375% 6/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Etsy Note 0.125%10/0 (Principal)
iShares MSCI Brazil Index Call Option (EWZ)
Activision Blizzard
Apple Call Option (AAPL)
Devon Energy Corporation Call Option (DVN)
Financial Select Sector SPDR Put Option (XLF)
Morgan Stanley Put Option (MS)
Exxon Mobil Corporation Put Option (XOM)
United States Stl Corp Note 5.000%11/0 (Principal)
Chipotle Mexican Grill Call Option (CMG)

View all positions for Mint Tower Capital Management B.V.

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1